☰

John A. Gray, M.D., Ph.D. - Publications

Affiliations: 
2014- Center for Neuroscience University of California, Davis, Davis, CA 
Area:
NMDA channels, synaptic plasticity, 5-HT2A
Website:
https://graylab.ucdavis.edu/
Tree Info Grants Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Barragan EV, Anisimova M, Vijayakumar V, Coblentz AC, Park DK, Salaka RJ, Nisan AFK, Petshow S, Dore K, Zito K, Gray JA. d-Serine inhibits non-ionotropic NMDA receptor signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 38942470 DOI: 10.1523/JNEUROSCI.0140-24.2024  0.77
2023 Folorunso OO, Brown SE, Baruah J, Harvey TL, Jami SA, Radzishevsky I, Wolosker H, McNally JM, Gray JA, Vasudevan A, Balu DT. D-serine availability modulates prefrontal cortex inhibitory interneuron development and circuit maturation. Scientific Reports. 13: 9595. PMID 37311798 DOI: 10.1038/s41598-023-35615-5  0.788
2023 González-González IM, Gray JA, Ferreira J, Conde-Dusman MJ, Bouchet D, Perez-Otaño I, Groc L. GluN3A subunit tunes NMDA receptor synaptic trafficking and content during postnatal brain development. Cell Reports. 42: 112477. PMID 37149869 DOI: 10.1016/j.celrep.2023.112477  0.388
2023 Vargas MV, Dunlap LE, Dong C, Carter SJ, Tombari RJ, Jami SA, Cameron LP, Patel SD, Hennessey JJ, Saeger HN, McCorvy JD, Gray JA, Tian L, Olson DE. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science (New York, N.Y.). 379: 700-706. PMID 36795823 DOI: 10.1126/science.adf0435  0.774
2023 Cameron LP, Patel SD, Vargas MV, Barragan EV, Saeger HN, Warren HT, Chow WL, Gray JA, Olson DE. 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines. Acs Chemical Neuroscience. PMID 36630260 DOI: 10.1021/acschemneuro.2c00718  0.776
2022 Park DK, Petshow S, Anisimova M, Barragan EV, Gray JA, Stein IS, Zito K. Reduced d-serine levels drive enhanced non-ionotropic NMDA receptor signaling and destabilization of dendritic spines in a mouse model for studying schizophrenia. Neurobiology of Disease. 170: 105772. PMID 35605760 DOI: 10.1016/j.nbd.2022.105772  0.798
2021 Berg EL, Jami SA, Petkova SP, Berz A, Fenton TA, Lerch JP, Segal DJ, Gray JA, Ellegood J, Wöhr M, Silverman JL. Excessive laughter-like vocalizations, microcephaly, and translational outcomes in the deletion rat model of Angelman Syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34475199 DOI: 10.1523/JNEUROSCI.0925-21.2021  0.732
2021 Jami SA, Cameron S, Wong JM, Daly ER, McAllister AK, Gray JA. Increased excitation-inhibition balance and loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction. Journal of Neurophysiology. PMID 34038186 DOI: 10.1152/jn.00661.2020  0.792
2020 Wong JM, Folorunso OO, Barragan EV, Berciu C, Harvey TL, Coyle JT, Balu DT, Gray JA. Postsynaptic serine racemase regulates NMDA receptor function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33158959 DOI: 10.1523/JNEUROSCI.1525-20.2020  0.809
2019 Chiu AM, Wang J, Fiske MP, Hubalkova P, Barse L, Gray JA, Sanz-Clemente A. NMDAR-Activated PP1 Dephosphorylates GluN2B to Modulate NMDAR Synaptic Content. Cell Reports. 28: 332-341.e5. PMID 31291571 DOI: 10.1016/J.Celrep.2019.06.030  0.553
2018 Minnella AM, Zhao JX, Jiang X, Jakobsen E, Lu F, Wu L, El-Benna J, Gray JA, Swanson RA. Excitotoxic superoxide production and neuronal death require both ionotropic and non-ionotropic NMDA receptor signaling. Scientific Reports. 8: 17522. PMID 30504838 DOI: 10.1038/S41598-018-35725-5  0.5
2018 Sun W, Wong JM, Gray JA, Carter BC. Incomplete block of NMDA receptors by intracellular MK-801. Neuropharmacology. PMID 30227149 DOI: 10.1016/J.Neuropharm.2018.09.022  0.658
2018 Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, Burbach KF, Soltanzadeh Zarandi S, Sood A, Paddy MR, Duim WC, Dennis MY, McAllister AK, Ori-McKenney KM, Gray JA, et al. Psychedelics Promote Structural and Functional Neural Plasticity. Cell Reports. 23: 3170-3182. PMID 29898390 DOI: 10.1016/J.Celrep.2018.05.022  0.753
2018 Crestani AP, Krueger JN, Barragan EV, Nakazawa Y, Nemes SE, Quillfeldt JA, Gray JA, Wiltgen BJ. Metaplasticity contributes to memory formation in the hippocampus. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29849054 DOI: 10.1038/S41386-018-0096-7  0.776
2018 Wong JM, Gray JA. Long-term depression is independent of GluN2 subunit composition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29593052 DOI: 10.1523/JNEUROSCI.0394-18.2018  0.661
2018 Yang XY, Stanley RE, Ross AP, Robitaille AM, Gray JA, Cheyette BNR. Sestd1 Encodes a Developmentally Dynamic Synapse Protein That Complexes With BCR Rac1-GAP to Regulate Forebrain Dendrite, Spine and Synapse Formation. Cerebral Cortex (New York, N.Y. : 1991). PMID 29474518 DOI: 10.1093/cercor/bhy026  0.45
2017 Yang XY, Stanley RE, Ross AP, Robitaille AM, Gray JA, Cheyette BNR. Sestd1 Encodes a Developmentally Dynamic Synapse Protein That Complexes With BCR Rac1-GAP to Regulate Forebrain Dendrite, Spine and Synapse Formation. Cerebral Cortex (New York, N.Y. : 1991). PMID 29293918 DOI: 10.1093/cercor/bhx333  0.521
2016 Gray JA, Zito K, Hell JW. Non-ionotropic signaling by the NMDA receptor: controversy and opportunity. F1000research. 5. PMID 27303637 DOI: 10.12688/f1000research.8366.1  0.565
2015 Stein IS, Gray JA, Zito K. Non-Ionotropic NMDA Receptor Signaling Drives Activity-Induced Dendritic Spine Shrinkage. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 12303-8. PMID 26338340 DOI: 10.1523/Jneurosci.4289-14.2015  0.571
2015 Stein IS, Gray JA, Zito K. Non-ionotropic NMDA receptor signaling drives activity-induced dendritic spine shrinkage Journal of Neuroscience. 35: 12303-12308. DOI: 10.1523/JNEUROSCI.4289-14.2015  0.468
2013 Sanz-Clemente A, Gray JA, Ogilvie KA, Nicoll RA, Roche KW. Activated CaMKII couples GluN2B and casein kinase 2 to control synaptic NMDA receptors. Cell Reports. 3: 607-14. PMID 23478024 DOI: 10.1016/J.Celrep.2013.02.011  0.638
2012 Chen BS, Gray JA, Sanz-Clemente A, Wei Z, Thomas EV, Nicoll RA, Roche KW. SAP102 mediates synaptic clearance of NMDA receptors. Cell Reports. 2: 1120-8. PMID 23103165 DOI: 10.1016/J.Celrep.2012.09.024  0.656
2012 Gray JA, Nicoll RA. Thinking outside the synapse: glycine at extrasynaptic NMDA receptors. Cell. 150: 455-6. PMID 22863001 DOI: 10.1016/j.cell.2012.07.013  0.663
2011 Gray JA, Shi Y, Usui H, During MJ, Sakimura K, Nicoll RA. Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron. 71: 1085-101. PMID 21943605 DOI: 10.1016/J.Neuron.2011.08.007  0.738
2011 Granger AJ, Gray JA, Lu W, Nicoll RA. Genetic analysis of neuronal ionotropic glutamate receptor subunits. The Journal of Physiology. 589: 4095-101. PMID 21768264 DOI: 10.1113/Jphysiol.2011.213033  0.798
2011 Lu W, Gray JA, Granger AJ, During MJ, Nicoll RA. Potentiation of synaptic AMPA receptors induced by the deletion of NMDA receptors requires the GluA2 subunit. Journal of Neurophysiology. 105: 923-8. PMID 20980546 DOI: 10.1152/Jn.00725.2010  0.798
2010 Juge N, Gray JA, Omote H, Miyaji T, Inoue T, Hara C, Uneyama H, Edwards RH, Nicoll RA, Moriyama Y. Metabolic control of vesicular glutamate transport and release. Neuron. 68: 99-112. PMID 20920794 DOI: 10.1016/j.neuron.2010.09.002  0.574
2009 Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annual Review of Medicine. 60: 355-66. PMID 19630576 DOI: 10.1146/Annurev.Med.60.042307.110802  0.603
2007 Gray JA, Roth BL. The pipeline and future of drug development in schizophrenia. Molecular Psychiatry. 12: 904-22. PMID 17667958 DOI: 10.1038/sj.mp.4002062  0.508
2007 Gray JA, Roth BL. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophrenia Bulletin. 33: 1100-19. PMID 17617664 DOI: 10.1093/schbul/sbm074  0.551
2006 Gray JA, Roth BL. Developing selectively nonselective drugs for treating CNS disorders Drug Discovery Today: Therapeutic Strategies. 3: 413-419. DOI: 10.1016/j.ddstr.2006.11.009  0.512
2003 Xia Z, Hufeisen SJ, Gray JA, Roth BL. The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro. Neuroscience. 122: 907-20. PMID 14643760 DOI: 10.1016/S0306-4522(03)00589-X  0.743
2003 Gray JA, Compton-Toth BA, Roth BL. Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization. Biochemistry. 42: 10853-62. PMID 12962510 DOI: 10.1021/bi035061z  0.609
2003 Gray JA, Bhatnagar A, Gurevich VV, Roth BL. The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalization. Molecular Pharmacology. 63: 961-72. PMID 12695524 DOI: 10.1124/Mol.63.5.961  0.701
2003 Xia Z, Gray JA, Compton-Toth BA, Roth BL. A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction. The Journal of Biological Chemistry. 278: 21901-8. PMID 12682061 DOI: 10.1074/jbc.M301905200  0.758
2002 Gray JA, Roth BL. Cell biology. A last GASP for GPCRs? Science (New York, N.Y.). 297: 529-31. PMID 12142517 DOI: 10.1126/science.1075453  0.537
2001 Gray JA, Roth BL. Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists. Brain Research Bulletin. 56: 441-51. PMID 11750789 DOI: 10.1016/S0361-9230(01)00623-2  0.596
2001 Gray JA, Sheffler DJ, Bhatnagar A, Woods JA, Hufeisen SJ, Benovic JL, Roth BL. Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells. Molecular Pharmacology. 60: 1020-30. PMID 11641430 DOI: 10.1124/Mol.60.5.1020  0.777
2001 Bhatnagar A, Willins DL, Gray JA, Woods J, Benovic JL, Roth BL. The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis. The Journal of Biological Chemistry. 276: 8269-77. PMID 11069907 DOI: 10.1074/Jbc.M006968200  0.717
1999 Gelber EI, Kroeze WK, Willins DL, Gray JA, Sinar CA, Hyde EG, Gurevich V, Benovic J, Roth BL. Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: the third intracellular loop is alpha-helical and binds purified arrestins. Journal of Neurochemistry. 72: 2206-14. PMID 10217304 DOI: 10.1046/J.1471-4159.1999.0722206.X  0.602
Show low-probability matches.